Literature DB >> 3158068

Immunological studies in acquired immunodeficiency syndrome. Functional studies of lymphocyte subpopulations.

B Hofmann, N Odum, P Platz, L P Ryder, A Svejgaard, J O Neilsen.   

Abstract

The lymphocyte transformation response in vitro to mitogens (phytohaemagglutinin, concanavalin A, and pokeweed mitogen) and antigens (purified protein derivative and tetanus) was studied in three patients with acquired immunodeficiency syndrome (AIDS), three patients with pre-AIDS, and six healthy controls before and after depletion of T4- or T8-positive cells. In controls, T8-depleted lymphocytes responded as well as peripheral blood mononuclear cells (PBMC) when monocytes were added, whereas T4-depleted cells gave about 50% of this response to mitogens and no response at all to antigens. No evidence of suppression was seen when various mixtures of T4- and T8-depleted cells were made. In particular, there was a virtually linear relationship between the percentage of T8-depleted cells and the response to antigens. The PBMC of all AIDS and pre-AIDS patients had very low or absent responses to mitogens and antigens, and except in one case, this response did not increase after depletion of T8-positive cells (and addition of monocytes), indicating that these patient cells also lack suppressor activity in this assay. However, a significantly increased response to mitogens was seen when the T8-depleted suspensions were adjusted to contain 20,000 T4-positive cells per well, but the response was still significantly lower than that of similar suspensions from controls. Thus, not only are the poor responses of PBMC from AIDS and pre-AIDS patients due to a low concentration of T4-positive cells, but the responsiveness of these cells also seems deficient. Furthermore, T8-positive patient cells also have an impaired responsiveness. Our experiments do not exclude the possibility that the low response is due to a T8-negative suppressor cell, but it seems more likely that both the T4- and the T8-positive cells are deficient and/or that there is a deficiency in accessory cells. These possibilities are currently under study.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3158068     DOI: 10.1111/j.1365-3083.1985.tb01426.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  10 in total

1.  Proliferative responses of blood mononuclear cells (BMNC) in a cohort of elderly humans: role of lymphocyte phenotype and cytokine production.

Authors:  H Bruunsgaard; A N Pedersen; M Schroll; P Skinhøj; B K Pedersen
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

2.  Abnormality of Leu 2+7+ cells in acquired immune deficiency syndrome (AIDS), AIDS-related complex, and asymptomatic homosexuals.

Authors:  S Gupta
Journal:  J Clin Immunol       Date:  1986-11       Impact factor: 8.317

3.  IgD production and other lymphocyte functions in HIV infection: immaturity and activation of B cells at different clinical stages.

Authors:  L A Rogers; S M Forster; A J Pinching
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

4.  Lymphocyte transformation induced by autologous cells: XVIII. Impaired autologous mixed lymphocyte reaction in subjects with AIDS-related complex.

Authors:  F C Garbrecht; G W Siskind; M E Weksler
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

5.  Microbicidal activity of monocyte derived macrophages in AIDS and related disorders.

Authors:  L J Eales; O Moshtael; A J Pinching
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

6.  Programmed cell death-10 enhances proliferation and protects malignant T cells from apoptosis.

Authors:  Britt Lauenborg; Katharina Kopp; Thorbjørn Krejsgaard; Karsten W Eriksen; Carsten Geisler; Sally Dabelsteen; Robert Gniadecki; Qian Zhang; Mariusz A Wasik; Anders Woetmann; Niels Odum
Journal:  APMIS       Date:  2010-08-19       Impact factor: 3.205

7.  Abnormalities of interleukin 2 receptor expression associated with decreased antigen-induced lymphocyte proliferation in patients with AIDS and related disorders.

Authors:  H E Prince; J K John
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

8.  Proliferation induced by Plasmodium falciparum antigen and interleukin-2 production by lymphocytes isolated from malaria-immune individuals.

Authors:  T G Theander; I C Bygbjerg; S Jepsen; M Svenson; A Kharazmi; P B Larsen; K Bendtzen
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

9.  Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.

Authors:  Nina A Sibbesen; Katharina L Kopp; Ivan V Litvinov; Lars Jønson; Andreas Willerslev-Olsen; Simon Fredholm; David L Petersen; Claudia Nastasi; Thorbjørn Krejsgaard; Lise M Lindahl; Robert Gniadecki; Nigel P Mongan; Denis Sasseville; Mariusz A Wasik; Lars Iversen; Charlotte M Bonefeld; Carsten Geisler; Anders Woetmann; Niels Odum
Journal:  Oncotarget       Date:  2015-08-21

Review 10.  Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma.

Authors:  Andreas Willerslev-Olsen; Thorbjørn Krejsgaard; Lise M Lindahl; Charlotte Menne Bonefeld; Mariusz A Wasik; Sergei B Koralov; Carsten Geisler; Mogens Kilian; Lars Iversen; Anders Woetmann; Niels Odum
Journal:  Toxins (Basel)       Date:  2013-08-14       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.